ASSESSING TREATMENT BENEFIT IN IMMUNO-ONCOLOGY
October 26, 2021
This webinar was presented by Laurence Collette, MSc, PhD, Principal Statistician, Consulting Services at IDDI at the 5th Annual Next Gen Immuno-Oncology Virtual Congress
WATCH RECORDED WEBINAR ASSESSING TREATMENT BENEFIT IN IMMUNO-ONCOLOGY
In this webinar, Dr. Collette discussed the immune response criteria and elaborate the quantifying benefits when the effect is non-proportional. She provided considerations for study monitoring.
Laurence Collette, MSc, PhD, Principal Statistician, Consulting Services at IDDI